Lv62
1640 积分 2024-10-25 加入
Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
29天前
已完结
Development of psoriasis during treatment with dupilumab: A systematic review
30天前
已完结
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis
1个月前
已完结
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
1个月前
已完结
Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study
1个月前
已完结
Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis
1个月前
已完结
Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment
1个月前
已完结
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era
1个月前
已完结
Tofacitinib in focus: Fascinating voyage from conventional formulations to novel delivery systems
1个月前
已完结
Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study
1个月前
已完结
皖公网安备34019202002308
